companydata.dkcompanydata.dk

Pharmaway Invest ApS: Financial statements 2021

CVR: 38585126

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

Pharmaway Invest ApS (CVR 38585126) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -22,305 and a net result of DKK -25,148 compared with DKK -25,399 the year before. Equity in the 2021 report amounted to DKK 48,064,070. The solvency ratio was 99.6%.

Gross Profit
DKK -22,305
Profit/Loss
DKK -25,148
Equity
DKK 48,064,070
Total Assets
DKK 48,243,618

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--22K-25K48.1M-
2020--23K-25K36.1M-
2019--13K-15K33.8M-
2018--4K-6K33.9M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Pharmaway Invest ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Pharmaway Invest ApS: The 2020 annual report is outJun 3, 2021

Pharmaway Invest ApS has published its annual report for 2020. Gross profit came to DKK -23,125, and the net result was DKK -25,399.

About Pharmaway Invest ApS

Pharmaway Invest ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2017. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Niels Ebbe Ebbesen. The company's owners include Ebbelykke ApS, Hundekurven ApS and Ebfos Family Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -23,125 and a net result of DKK -43,449,506 compared with DKK -38,583 the year before. Equity in the 2025 report amounted to DKK 4,538,851.

Source: annual report 2025, Danish Business Authority

Other financial years